SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr | ₹11 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹59 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹11 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | 82.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,877.1 Cr | 3.5% | 30% | 123.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 3.5% |
30% |
123.2% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses